Clinical Trials on Respiratory Syncytial Virus (RSV) Infection in Switzerland

Total 473 results

University Hospital, Geneva
ModernaTX, Inc.; University of Geneva, Switzerland

Active, not recruiting

Mucosal Immunity: Influence on Infectious Viral Load: a Prospective Observational Study (MIViral)

SARS-CoV-2 Infection | RSV Infection | Influenza Viral Infections | Virus Shedding | Mucosal Immunity

Switzerland
Gilead Sciences

Completed

Presatovir in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus (RSV) Infection of the Lower Respiratory Tract

Respiratory Syncytial Virus Infection

United States, France, Sweden, Korea, Republic of, Switzerland
Luzerner Kantonsspital

Completed

Effects of Prone Positioning on Vital Parameters in Infants With Acute Bronchiolitis

Infant, Premature, Diseases | Respiratory Syncytial Virus (RSV) | Infant, Newborn, Disease | Acute Bronchiolitis

Switzerland
Gilead Sciences

Completed

Presatovir in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus Infection of the Upper Respiratory Tract

Respiratory Syncytial Virus

Korea, Republic of, Taiwan, Israel, United States, France, Singapore, Sweden, Australia, Canada, United Kingdom, Brazil, Germany, Netherlands, Spain, Switzerland
University of Zurich

Recruiting

Microbiota in COVID-19 Patients for Future Therapeutic and Preventive Approaches (MICRO-COV)

Corona Virus Infection | ARDS | Coinfection

Switzerland
A. Vogel AG

Completed

Echinacea Junior vs Vitamin C in Children 4-12 Years Old

Respiratory Tract Infection Viral

Switzerland
Novartis
Novartis Vaccines

Completed

Safety, Tolerability, Immunogenicity And CPG Dosage Finding Study of Novartis CpG Adjuvanted Flu Vaccine

Influenza Infection

Switzerland
Prof. Dr. Jörg Leuppi

Terminated

Inhaled Aviptadil for the Treatment of COVID-19 in Patients at High Risk for ARDS

Covid19 | Corona Virus Infection | ARDS | Aviptadil

Switzerland
University Hospital, Basel, Switzerland

Completed

Amotosalen-Ultraviolet A Pathogen-Inactivated Convalescent Plasma in Addition to Best Supportive Care and Antiviral Therapy on Clinical Deterioration in Adults Presenting With Moderate to Severe COVID-19

Coronavirus Disease 2019 Infectious Disease (COVID-19 Infection)

Switzerland
Foundation for Innovative New Diagnostics, Switzerland

Completed

COVID-19 Novel Molecular Point of Care Diagnostics Evaluation

COVID-19 Respiratory Infection

Switzerland, Uganda, United Kingdom
University Hospital, Basel, Switzerland
ETH Zurich (Switzerland); Health Department of the Canton of Basel-Stadt

Completed

COVID-19 in Baselland: Investigation and Validation of Serological Diagnostic Assays and Epidemiological Study of Sars-CoV-2 Specific Antibody Responses (SEROBL-COVID19)

COVID-19 Infection

Switzerland
Ricardo Pereira Mestre
Oncology Institute of Southern Switzerland; Institute of Oncology Research; Institute...

Terminated

Randomized Open Label Phase II Study to Evaluate the Efficacy of Enzalutamide in High Risk Male Outpatients With COVID-1

COVID-19 Infection

Switzerland
University Hospital, Geneva

Completed

Outcomes in Hospitalized Older Patients With COVID-19

Coronavirus Infection | Old Age; Debility | Elderly Infection | Sars-CoV2

Switzerland
Kantonsspital Winterthur KSW

Unknown

Quality of Life and Physical Performance After Novel Coronavirus Infection (COVID-19);

Covid-19 (New Coronavirus) Infection

Switzerland
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity Study of the Influenza Vaccine in Adults

Influenza | Orthomyxoviridae Infections

Belgium, Germany, Switzerland
Emergex Vaccines Holding Ltd.
University of Lausanne Hospitals; Center for Primary Care and Public Health...

Completed

A Phase-I Study of a Nanoparticle-based Peptide Vaccine Against SARS-CoV-2

COVID-19 | Coronavirus | SARS-CoV-2 Infection

Switzerland
University of Bern
Interregionale Blutspende SRK Bern

Unknown

Police COVID-19 Serosurvey (PoliCOV)

Healthy | Volunteers | SARS-CoV-2 Infection

Switzerland
University Hospital, Geneva

Completed

A Comparison of Cotton and Flocked Swabs for Vaginal Self Collection

Human Papillomavirus Infection

Switzerland
Patricia Schlagenhauf
University Hospital, Geneva; Swiss Tropical & Public Health Institute; ETH Zurich and other collaborators

Not yet recruiting

Infection Tracking in Travellers. The Project Aims to Identify Profiles of Travel-associated Illness and to Follow up on Long-term Sequelae of Arboviral Infections and Malaria (ITIT)

Diarrhea | Malaria | Influenza | SARS-CoV Infection | Dengue | Chikungunya | Zika | Travel-Related Illness | MERS

Switzerland
University Hospital Inselspital, Berne
Roche Pharma AG

Terminated

Tocilizumab in the Treatment of Coronavirus Induced Disease (COVID-19) (CORON-ACT)

SARS-CoV-2 Infection

Switzerland
University Hospital Inselspital, Berne
University of Bern

Completed

Characterizing the Immune Response and Neuronal Damage in COVID-19

Covid-19 | SARS-CoV Infection

Switzerland
University Hospital, Basel, Switzerland
ETH Zurich Department for Biosystems, Science and Engineering; Kanton Basel-...

Recruiting

COVID-19 in Baselland: Validation of Simple and Accurate Tests for COVID-19 Detection, Monitoring and Tracing (ACCURATE-BL-COVID-19)

Coronavirus Infectious Disease 2019 (COVID-19)

Switzerland
Hervé SPECHBACH
OM Pharma SA

Completed

Assessment of the Efficacy of Calcium Dobesilate vs. Placebo on SARS-CoV-2 Viral Load Amongst Outpatients With COVID-19. (COVID-19)

COVID-19 Virus Disease

Switzerland
University Hospital, Basel, Switzerland
sciCORE University of Basel; Leonhard Med IT ETH Zurich; Swiss Institute of Bioinformatics

Completed

A Systems Approach to Predict the Outcome of SARS-CoV-2 in the Population of a City; COVID-19

SARS Coronavirus (SARS-CoV-2) Infection

Switzerland
University Hospital Inselspital, Berne
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company

Terminated

CorONa Virus edoxabaN ColchicinE (CONVINCE) COVID-19 (CONVINCE)

COVID-19 | SARS-CoV Infection

Belgium, Switzerland, Italy
Prof. Dr. Jörg Leuppi

Completed

High Dose Vitamin-D Substitution in Patients With COVID-19: a Randomized Controlled, Multi Center Study (VitCov)

Covid19 | Vitamin D Deficiency | Corona Virus Infection | ARDS | SARS-CoV Infection | Coronavirus

Switzerland
AiCuris Anti-infective Cures AG
Medpace, Inc.

Recruiting

Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections in Immunocompromised Subjects (PRIOH-1)

HSV Infection

United States, Italy, Belgium, France, United Kingdom, Germany, Switzerland, Argentina, Australia, Georgia, Greece, Mexico, Israel, Canada
University Hospital, Geneva
Prof Laurent Kaiser; Dr Samuel Cordey; Dr Stavroula Masouridi-Levrat; Prof Christian... and other collaborators

Completed

DNA and RNA Viruses of the Blood Virome of Allogeneic Hematopoietic Stem Cell Transplant Recipients (GeBVir)

RNA Virus Infections | DNA Virus Infections | Hematopietic Stem Cell Transplantation | Blood Virome

Switzerland
Insel Gruppe AG, University Hospital Bern

Terminated

Intensive Care Associated Complications and Outcome of Acute Respiratory Distress Syndrome Due to COVID-19

COVID | Corona Virus Infection | Sars-CoV2

Switzerland
University Hospital, Geneva
Ligue Pulmonaire Genevoise

Completed

Viral Infections in Chronic Obstructive Pulmonary Disease (COPD) Exacerbations (VICE)

Virus Diseases | Respiratory Tract Infections | Lung Diseases, Obstructive | Pulmonary Disease, Chronic Obstructive

Switzerland
Goldhahn Jörg

Completed

Spread and Course of COVID-19 Infections (CoV-ETH)

Covid-19 | Virus Disease

Switzerland
A. Vogel AG
University Children's Hospital, Zurich

Withdrawn

Echinaforce Junior Bioavailability Trial

Common Cold

Switzerland
University Hospital, Basel, Switzerland
University of Basel; Swiss Federal Institute of Technology; University Children...

Completed

Prospective Analysis of Seasonal Influenza - Viral Transmission and Evolution in the City of Basel, Switzerland

Influenza

Switzerland
Crucell Holland BV

Completed

Re-licensing Study to Assess Inflexal V Formulated With WHO Recommended Influenza Strains (2013-14)

Influenza

Switzerland
Johannes Scherr

Recruiting

GRIP: Maximum Isometric Grip Strength Assessed With Three Different Hand-held Dynamometers

Grip

Switzerland
Crucell Holland BV

Completed

Re-licensing Study to Assess Virosomal Influenza Vaccine Formulated With WHO Recommended Influenza Strains

Influenza

Switzerland
Novartis Vaccines

Completed

Study to Evaluate Safety, Tolerability and Immunogenicity of a Bedside Mixing Combination of Two Adjuvanted Influenza Vaccines

Influenza

Switzerland
Crucell Holland BV

Completed

Re-licensing Study to Assess Inflexal V Formulated With WHO Recommended Influenza Strains

Influenza

Switzerland
Crucell Holland BV

Completed

A Re-licensing Study to Assess the Efficacy of Inflexal V Formulated With WHO Recommended 2008/2009 Influenza Virus Strains for the Northern Hemisphere

Influenza

Switzerland
Crucell Holland BV

Completed

A Re-licensing Study to Assess the Efficacy of Inflexal V Formulated With WHO Recommended 2010/2011 Influenza Virus Strains for the Northern Hemisphere

Influenza

Switzerland
Crucell Holland BV

Completed

Immunogenicity and Safety Study to Assess Influenza Vaccine Formulated With Haemagglutinin (HA) Antigen From Two Different Suppliers

Influenza

Switzerland
Crucell Holland BV

Completed

A Re-licensing Study to Assess the Efficacy of Inflexal V Formulated With WHO Recommended 2009/2010 Influenza Virus Strains for the Northern Hemisphere

Influenza

Switzerland
University Hospital, Basel, Switzerland

Recruiting

Occurrence of Antibodies Cross-reacting With Autoantigens in Primary EBV Infection

Epstein-Barr Virus (EBV) Infection

Switzerland
University Hospital, Geneva

Completed

Knowledge and Attitudes Towards Human Papillomavirus Infections and HPV Vaccination

HPV-Related Cervical Carcinoma

Switzerland
University Hospital, Basel, Switzerland

Completed

Herpes Zoster: Risk Factors, Complications and Special Situations

Herpes Zoster

Switzerland
Crucell Holland BV

Completed

Immunogenicity and Safety Study to Assess Influenza Vaccine Formulated With Haemagglutinin (HA) Antigen From Two Suppliers

Influenza

Switzerland
Sanofi Pasteur, a Sanofi Company

Completed

Study of Influenza Vaccine (Split Virion, Inactivated) Northern Hemisphere 2009-2010 Formulation

Influenza

Switzerland
University of Zurich
Schweizerischer Nationalfonds

Completed

Transmission of Influenza Virus From Asymptomatic Healthcare Workers and Inpatients in the Acute Care Hospital Setting (TransFLUas)

Human Influenza

Switzerland
University Hospital, Basel, Switzerland
Pharming Technologies B.V.

Terminated

Conestat Alfa in the Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19

Coronavirus Infections

Switzerland, Brazil, Mexico
University of Zurich
Swiss National Science Foundation; University Hospital, Zürich; ETH Zurich; Kantonsspital...

Not yet recruiting

Clinical Efficiency of Surgical Masks and Filtering Face-piece 2 Masks

Covid19

Switzerland

Clinical Trials on Respiratory Syncytial Virus (RSV) Infection in Switzerland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kyrgyzstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations